Clinical Trial Update: Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a chemotherapy regimen in combination with PSC-833 (valspodar) for children with refractory or relapsed acute le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• PSC 833 (valspodar)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Leukemia | Phase 1 | Status: COMPLETED